Immunic market cap
WitrynaImmunic (IMUX) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Enterprise Value/Market Cap N/A. Enterprise Value/Revenue N/A. Enterprise Value/Gross Profit-10.00T> Enterprise Value/Ebitda 0.53. Forecast. 1Y Price Target. … Witryna10 paź 2024 · Immunic anticipates the gross proceeds from the PIPE to be approximately $60.0 million, before deducting any offering related expenses. The financing is expected to close on October 12, 2024 ...
Immunic market cap
Did you know?
Witryna10 godz. temu · Mark Mobius, seasoned investor and founder of Mobius Capital, believes that the concerns around the Indian ports-to-energy conglomerate Adani Group were overblown by Hindenburg Research, the ... Witryna10 sie 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] Or. Rx Communications Group Melody Carey +1-917-322-2571 [email protected] SOURCE ...
Witryna2 dni temu · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC). Vitt describes it as "wonderful data" that came as a "positive … Witryna6 kwi 2024 · Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need – Conference Call and Webcast to be Held Today, February 9, 2024, at 11:00 am ET – NEW YORK , Feb. 9, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage …
WitrynaCurrent and historical total assets on balance sheet for Immunic. companies: 7,318 total market cap: $84.336 T. Global ranking; Ranking by countries. America ... The … Witryna31 mar 2024 · Immunic has a market cap or net worth of $66.16 million as of April 1, 2024. Its market cap has decreased by -79.28% in one year. Market Cap 66.16M. …
WitrynaMarket Cap-1M Daily Avg. Vol-3Y P/B Range - 52W Range - 3Y P/S Range - 3Y DivYield Range - Company Info. more arrow_right. Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerat...
WitrynaCompany information for Immunic Inc USD0.0001 share priceincluding general stock details, key personnel and important dates for your diary. ... Market cap: $78.15 million Shares in issue: 44.40 ... optimizewithosqpWitrynaImmunic started at outperform with $40 stock price target at BMO Capital Jul. 20, 2024 at 8:37 a.m. ET by Tomi Kilgore Immunic started at outperform with $59 stock price target at Wedbush optimizing a mobile hotspot for online gamingWitryna13 kwi 2024 · IMMUNIC, INC. : Veränderung des Consensus und Kursziel der Analysten der Aktie IMMUNIC, INC. IMUX US4525EP1011 Nasdaq portland oregon security companiesWitrynaImmunic market cap history and chart from 2013 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly … portland oregon self improvementWitrynaMarket Cap is a widely used stock evaluation measure. Find the latest Market Cap for Immunic (IMUX) portland oregon science museumWitrynaContact Email [email protected]. Phone Number +4989208047700. Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The company is developing three small molecule products; its lead development program, … portland oregon section 8 apartmentsWitryna3 lis 2024 · Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update. News provided by. Immunic, Inc. Nov 03, 2024, 06:30 ET. – $72.8 Million in Cash and Cash Equivalents as ... optimizing aav safety summit hanson wade